David Lack1, Richard I G Holt2, David S Baldwin3. 1. Alexandra Hospital, Worcestershire Acute NHS Trust, Redditch, UK. 2. Human Development and Health Academic Unit, Faculty of Medicine, University of Southampton, UK. 3. Professor of Psychiatry, Clinical and Experimental Sciences Academic Unit, Faculty of Medicine, University of Southampton, University Department of Psychiatry, 4-12 Terminus Terrace, Southampton, SO14 3DT, UK.
Abstract
BACKGROUND: Severe mental illness is associated with significantly increased morbidity and mortality, most commonly from cardiovascular disease. Much of the risk is explicable by potentially modifiable factors such as diabetes and dyslipidaemia, and regular screening of patients with severe mental illness is recommended. Screening and intervention for physical illness among people with schizophrenia is often suboptimal, but little is known about monitoring physical health in patients with affective (mood and anxiety) disorders. METHOD: Electronic and paper records were examined for evidence of monitoring of cardiovascular disease risk factors in the 12 months prior to assessment in patients attending a tertiary referral specialist service for affective disorders over a period of 39 months. The number of contacts with healthcare services was calculated for each patient to provide an estimate of the opportunities for monitoring. RESULTS: Notes for 113 patients were examined. The mean number of contacts with outpatient services in the 12 months before assessment was 6.9 (standard deviation 7.7). Documented evidence of physical-health monitoring was seen in only 29 patients: monitoring was more commonly undertaken in patients with recurrent unipolar depression and in those who had undergone recent inpatient treatment. Contacts that could have allowed monitoring of physical health were common. DISCUSSION: Although most patients had multiple contacts with health services in the 12-month period before their assessment in the service, there was little evidence of use of primary-prevention measures to reduce the risks of diabetes and cardiovascular disease in this vulnerable population.
BACKGROUND: Severe mental illness is associated with significantly increased morbidity and mortality, most commonly from cardiovascular disease. Much of the risk is explicable by potentially modifiable factors such as diabetes and dyslipidaemia, and regular screening of patients with severe mental illness is recommended. Screening and intervention for physical illness among people with schizophrenia is often suboptimal, but little is known about monitoring physical health in patients with affective (mood and anxiety) disorders. METHOD: Electronic and paper records were examined for evidence of monitoring of cardiovascular disease risk factors in the 12 months prior to assessment in patients attending a tertiary referral specialist service for affective disorders over a period of 39 months. The number of contacts with healthcare services was calculated for each patient to provide an estimate of the opportunities for monitoring. RESULTS: Notes for 113 patients were examined. The mean number of contacts with outpatient services in the 12 months before assessment was 6.9 (standard deviation 7.7). Documented evidence of physical-health monitoring was seen in only 29 patients: monitoring was more commonly undertaken in patients with recurrent unipolar depression and in those who had undergone recent inpatient treatment. Contacts that could have allowed monitoring of physical health were common. DISCUSSION: Although most patients had multiple contacts with health services in the 12-month period before their assessment in the service, there was little evidence of use of primary-prevention measures to reduce the risks of diabetes and cardiovascular disease in this vulnerable population.
Entities:
Keywords:
affective disorder; monitoring; physical health
Authors: Marc De Hert; Dan Cohen; Julio Bobes; Marcelo Cetkovich-Bakmas; Stefan Leucht; David M Ndetei; John W Newcomer; Richard Uwakwe; Itsuo Asai; Hans-Jurgen Möller; Shiv Gautam; Johan Detraux; Christoph U Correll Journal: World Psychiatry Date: 2011-06 Impact factor: 49.548
Authors: Roger S McIntyre; Marlon Danilewitz; Samantha S Liauw; David E Kemp; Ha T T Nguyen; Linda S Kahn; Aaron Kucyi; Joanna K Soczynska; Hanna O Woldeyohannes; Angela Lachowski; Byungsu Kim; Jay Nathanson; Mohammad Alsuwaidan; Valerie H Taylor Journal: J Affect Disord Date: 2010-06-12 Impact factor: 4.839
Authors: Thomas R E Barnes; Carol Paton; Mary-Rose Cavanagh; Elizabeth Hancock; David M Taylor Journal: Schizophr Bull Date: 2007-05-04 Impact factor: 9.306
Authors: Ruud van Winkel; Jim van Os; Ivan Celic; Dominique Van Eyck; Martien Wampers; Andre Scheen; Joseph Peuskens; Marc De Hert Journal: J Clin Psychiatry Date: 2008-08 Impact factor: 4.384
Authors: William T Regenold; Ramesh K Thapar; Christopher Marano; Sridevi Gavirneni; Prasad V Kondapavuluru Journal: J Affect Disord Date: 2002-06 Impact factor: 4.839
Authors: R I G Holt; T Abdelrahman; M Hirsch; Z Dhesi; T George; T Blincoe; R C Peveler Journal: J Psychopharmacol Date: 2009-03-20 Impact factor: 4.153
Authors: Sandra M Meier; Manuel Mattheisen; Ole Mors; Preben B Mortensen; Thomas M Laursen; Brenda W Penninx Journal: Br J Psychiatry Date: 2016-07-07 Impact factor: 9.319
Authors: Ella Zomer; David Osborn; Irwin Nazareth; Ruth Blackburn; Alexandra Burton; Sarah Hardoon; Richard Ian Gregory Holt; Michael King; Louise Marston; Stephen Morris; Rumana Omar; Irene Petersen; Kate Walters; Rachael Maree Hunter Journal: BMJ Open Date: 2017-09-05 Impact factor: 2.692